Nicole Leber | Investor Relations |
Panna Sharma | Chief Executive Officer |
David Margrave | Chief Financial Officer |
Good afternoon, everyone. I’m Nicole Leber with Investor Relations here at Lantern Pharma. And welcome to our Second Quarter 2022 Earnings Call. I will be your host for today's call.
As a reminder, this call is being recorded and all attendees are in a listen-only mode.